Prudential Jennison Health Sciences Fund Class B (PHLBX)

41.43
Net Asset Value
+1.12%
1 Day
+4.99%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.88%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector. It will invest in securities of issuers among a number of different countries throughout the world, one of which may be the United States. The portfolio managers use fundamental and quantitative analyses to select individual securities, and they may invest more than 5% of the fund's assets in any one issuer. The fund participates in the initial public offering (IPO) market. It is non-diversified.

Performance

1 month+3.07% 3 years+35.71%
3 months+12.54% 5 years+28.20%
1 year+30.20% Since inception+16.71%
Data through --

Peer Comparisonvs. Health

 PHLBXCategory
Performance 5-yr return+28.20%+21.57%
Expense ratio1.88%1.45%
Risk 5 year sharpe ratio1.481.44
Net assets$3.1B$3.3B
Average market cap$12.3B$34.2B
Average P/E31.925.1
Portfolio turnover57%57%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Investments
Fund manager & tenureDavid Chan / 15 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock79.07%
International stock15.26%
Cash4.32%
Fixed income1.35%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 97.95%
Consumer service 1.34%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BMRN Biomarin Pharmaceutical Inc5.31%
-- Covidien PLC5.22%
ALXN Alexion Pharmaceuticals Inc4.36%
INCY Incyte Corp Ltd4.10%
VRTX Vertex Pharmaceuticals Inc2.93%
-- Roche Holding AG Dividend Right Cert.2.90%
ALNY Alnylam Pharmaceuticals Inc2.67%
ACT Actavis PLC2.62%
PCRX Pacira Pharmaceuticals Inc2.59%
ISIS Isis Pharmaceuticals2.53%

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.